Stanford Cancer Institute
Stanford University Stanford, California
The Stanford Cancer Institute at Stanford University was founded in 2003 and received its NCI designation in 2007. The Institute is a consortium cancer center encompassing Stanford University and the Cancer Prevention Institute of California (CPIC). The Institute’s research efforts are focused on improving the diagnosis, treatment and outcomes for cancer patients, as well as understanding cancer etiologies among diverse populations and reducing the incidence of cancer.
The Institute draws on the expertise of more than 400 faculty, both researchers and clinicians, from the Schools of Medicine, CPIC and Stanford University, who participate in basic, translational and clinical research. Stanford’s strengths in basic science, biostatistics, bioengineering and technology have facilitated the development of new approaches to cancer etiology, prevention, diagnosis and treatment. The Institute’s members have contributed in the areas of new radiology techniques, antibody and biologic therapies, and new surgical techniques used to treat cancers.
Research at Stanford is typically interdisciplinary, involving experts from a number of fields. Key areas of research include cancer stem cells, radiation biology, cancer biology, cancer imaging, molecular therapeutics, lymphoma and Hodgkin disease, immunology and immunotherapy, hematopoietic cell transplantation, cancer epidemiology and cancer prevention and control.
Collaborations between the laboratory scientists and clinicians facilitate the translation of scientific research and technical advances into improved patient care. The Institute’s clinical partners include Stanford Health Care, Lucile Packard Children’s Hospital Stanford and the Palo Alto Veteran’s Hospital.
Training of the next generation of cancer researchers takes place in several different programs in clinical and basic sciences. There are doctoral programs in cancer biology and immunology. In addition to research training programs, Stanford offers continuing medical education in the latest advances in cancer medicine.
Translational research is at the heart of the Institute’s programs. Investigators gain new insights into the genetic, behavioral and environmental factors that can impact an individual’s risk for cancer and the prognosis following a cancer diagnosis. The transformation of those insights into improved public health is central to Stanford’s mission. The Institute provides the latest information in cancer prevention and promotes access to cancer screening services and clinical trials through a number of outreach initiatives. As part of this effort across the San Francisco Bay area, members of the Institute work closely with community-based organizations to address the unequal burden of cancer in medically underserved populations.
At the same time, Stanford conducts clinical trials, engaging in active recruitment throughout the greater Bay area to ensure the broadest possible access to these emerging therapies. Particular emphasis is placed on engaging minority and medically underserved populations.
* This profile was provided by the Stanford Cancer Institute.